Clinical Trial Update: Quality of Life Intermittent Catheter Study [Phase 4]

View source ↗

Summary

Coloplast A/S completed a Phase 4 trial assessing quality of life with intermittent catheterization for neurogenic bladder dysfunction; results were posted in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurogenic Bladder

Snippet

Sponsor: Coloplast A/S | Conditions: Neurogenic Bladder Dysfunction Nos | Phase 4 | Status: COMPLETED | Results posted: 2014-05-22